BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10971744)

  • 1. Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor.
    Fukuchi K; Li L; Hart M; Lindsey JR
    Int J Exp Pathol; 2000 Aug; 81(4):231-9. PubMed ID: 10971744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice overexpressing both amyloid beta-protein and perlecan in pancreatic acinar cells.
    Fukuchi K; Hart M; Yan Z; Hassell JR; Li L
    Histol Histopathol; 2004 Jul; 19(3):845-52. PubMed ID: 15168347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
    Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
    Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of beta-amyloid fibrils in pancreas of transgenic mice.
    Kawarabayashi T; Shoji M; Sato M; Sasaki A; Ho L; Eckman CB; Prada CM; Younkin SG; Kobayashi T; Tada N; Matsubara E; Iizuka T; Harigaya Y; Kasai K; Hirai S
    Neurobiol Aging; 1996; 17(2):215-22. PubMed ID: 8744402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related amyloid beta protein accumulation induces cellular death and macrophage activation in transgenic mice.
    Shoji M; Kawarabayashi T; Sato M; Sasaki A; Saido TC; Matsubara E; Tomidokoro Y; Kanai M; Shizuka M; Ishiguro K; Ikeda M; Harigaya Y; Okamoto K; Hirai S
    J Pathol; 2000 May; 191(1):93-101. PubMed ID: 10767725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E accumulates with the progression of A beta deposition in transgenic mice.
    Igeta Y; Kawarabayashi T; Sato M; Yamada N; Matsubara E; Ishiguro K; Kanai M; Tomidokoro Y; Osuga J; Okamoto K; Hirai S; Shoji M
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1228-35. PubMed ID: 9370233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of amyloid beta protein in transgenic mice.
    Shoji M; Kawarabayashi T; Sato M; Sasaki A; Matsubara E; Igeta Y; Kanai M; Tomidokoro Y; Shizuka M; Ishiguro K; Harigaya Y; Okamoto K; Hirai S
    Neurobiol Aging; 1998; 19(1 Suppl):S59-63. PubMed ID: 9562470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.
    Jin LW; Hearn MG; Ogburn CE; Dang N; Nochlin D; Ladiges WC; Martin GM
    Am J Pathol; 1998 Dec; 153(6):1679-86. PubMed ID: 9846957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.
    Jankowsky JL; Slunt HH; Gonzales V; Savonenko AV; Wen JC; Jenkins NA; Copeland NG; Younkin LH; Lester HA; Younkin SG; Borchelt DR
    PLoS Med; 2005 Dec; 2(12):e355. PubMed ID: 16279840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice.
    Frackowiak J; Miller DL; Potempska A; Sukontasup T; Mazur-Kolecka B
    J Neuropathol Exp Neurol; 2003 Jun; 62(6):685-96. PubMed ID: 12834113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H
    Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic overexpression of a C-terminal fragment of human amyloid beta-protein precursor causes accumulation of Alzheimer beta-amyloid fibrils in pancreas of transgenic mice.
    Shoji M; Kawarabayashi T; Sato M; Sasaki A; Matsubara E; Iizuka T; Harigaya Y; Hirai S
    Gerontology; 1996; 42 Suppl 1():48-56. PubMed ID: 8964522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
    Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
    Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
    Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate-like amyloid-beta sequence but no cerebral amyloidosis in aged tree shrews.
    Pawlik M; Fuchs E; Walker LC; Levy E
    Neurobiol Aging; 1999; 20(1):47-51. PubMed ID: 10466892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.